跳至主要内容
临床试验/KCT0002208
KCT0002208招募中未知

A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial

Gil Korean Medicine Hospital, Gachon University0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 65(Year)(—)
性别
Female

入选标准

  • Female aged 18 to 65 years
  • - Subject must included at least one or more of the following symptoms below
  • ? Body Mass Index of 30 kg/? or more;
  • ? Body Mass Index between 25 and 29.9kg/? with hypertension, taking medication or systolic blood pressure = 140mmHg or diastolic blood pressure = 90mmHg at the screening visit
  • ? Body Mass Index between 25 and 29.9kg/? with non-insulin-dependent diabetes mellitus, taking medication or fasting blood glucose > 126mg/dL at the screening visit
  • ? Body Mass Index between 25 and 29.9kg/? with hyperlipidemia, taking medication or total cholesterol = 200mg/dL or Triglyceride = 150mg/dL at screening visit
  • - Agreed to low-calorie diet during the trial
  • - Written informed consent of the trial

排除标准

  • - Endocrine diseases associated with weight gain, such as hypothyroidism, Cushing's syndrome, etc.
  • - Heart disease (heart failure, angina pectoris, myocardial infarction)
  • - Cholelithiasis
  • - Severe renal disability (serum creatinine concentration > 2.0 mg/dL)
  • - Severe liver disability (2.5 fold of normal high range value on Alanine Aminotransferase [ALT], Aspartate Aminotransferase [AST], alkaline phosphatase)
  • - History of narrow angle glaucoma
  • - History of stroke or temporary ischemic cardioplegia
  • - History of eating disorder such as anorexia nervosa or bulimia nervosa, etc.
  • - Use of medication that can affect on weight within last 3 months (appetite suppressant, laxative, oral steroid, thyroid hormone, amphetamine, cyproheptadine, phenothiazine or medications can affect on absorption, metabolism, excretion)
  • - Use of central nerve system(CNS) stimulant medication for weight loss
  • - Forbidden treatment (Insulin, hypoglycemic agent, antidepressant, antiserotonin agent, barbiturate, antipsychotic, medication concerns of abuse)
  • - history of weight loss surgery, such as bariatric surgery, etc.
  • - Subjects who are judged to be inappropriate for the clinical study by the researchers
  • - Women who were pregnant, lactating or have the chances of pregnancy who do not agree to proper contraception (birth-control pill, hormone implant, intrauterine device, spermicide, condom, abstinence, etc.)
  • - Use of other investigational product within last 1 month
  • - 10 percent reduction in body weight over 6 months
  • - Decided to quit smoking over the last 3 months or have irregular smoking habits

研究者

发起方
Gil Korean Medicine Hospital, Gachon University

相似试验

已完成
不适用
Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute ExacerbatioIdiopathic pulmonary fibrosis
JPRN-UMIN000013116ippon Medical School Hospital20
进行中(未招募)
1 期
A preliminary study to assess if low dose iron is safe and effective in patients with inflammatory bowel diseaseIron deficiency anaemia in inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851MedDRA version: 20.1Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2018-002982-20-GBRoyal Liverpool University Hospital30
进行中(未招募)
不适用
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersNon Familial Chylomicronemia Syndrome (Non-FCS)
EUCTR2012-000872-40-CZovartis Pharma Services AG60
已完成
3 期
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infants
JPRN-UMIN000015061agano Children's Hospital10
已完成
3 期
A preliminary safety study comparing the concentration of a local anaesthetic absorbed into the blood (when trickling near the surgical site for 96hours after surgery) to published threshold for toxicityBowel Cancer SurgeryCancer - Bowel - AnalCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileumAnaesthesiology - Pain managementSurgery - Other surgery
ACTRN12605000413628TQEH Research Foundation10